The Limited Times

Now you can see non-English news...

Hydroxychloroquine: the debate continues

2020-06-03T23:19:27.753Z

The question of its relevance to the Covid-19 is still facing the lack of quality data.The debate on hydroxychloroquine is decidedly far from settled… While some countries continue to promote the molecule (Brazil, Algeria, Morocco…), two studies published on May 14 in the British Medical Journal , one carried out by a French team, the other Chinese, have just dealt him a new blow. Their conclusions join those of several previous studies: hydroxychloroquine is not effective in people...



The debate on hydroxychloroquine is decidedly far from settled… While some countries continue to promote the molecule (Brazil, Algeria, Morocco…), two studies published on May 14 in the British Medical Journal , one carried out by a French team, the other Chinese, have just dealt him a new blow. Their conclusions join those of several previous studies: hydroxychloroquine is not effective in people infected with Sars-CoV-2, whether it is to make the virus disappear from the body, to avoid a passage in intensive care or death, even if it is given within 48 hours of admission to hospital.

Read also: Chloroquine: three months of infatuation, controversy and confusion

At the same time, a study published in the journal The Lancet recently highlighted a significant excess mortality in the treated patients. The study, although highly criticized for inconsistencies in the data and the lack of transparency regarding their origin, still led the World Health Organization to

This article is for subscribers only. You still have 80% to discover.

Subscribe: € 1 the first month

cancellable at any time

Enter your email

Already subscribed? Log in

Source: lefigaro

You may like

Tech/Game 2020-06-03T23:19:27.753Z

Trends 24h

Tech/Game 2020-07-05T09:27:51.877Z
Tech/Game 2020-07-05T18:50:35.487Z

Latest

tech 2020/07/04    

© Communities 2019 - Privacy